Revises provisions relating to public health. (BDR 40-86)
SB192 is a broad public health bill that makes changes across hospital care, insurance coverage, child welfare, nursing regulation, and medical practice standards. It requires hospitals and freestanding birthing centers to notify deaf or hard-of-hearing laboring patients that a qualified sign language interpreter is available, and to provide that interpreter when requested unless doing so would be impractical or delay necessary care. It also gives birthing patients the right to have a family member and a doula present during labor, subject to facility policies.
The bill expands insurance coverage in several ways. It requires a wide range of public and private health plans that cover maternity care to include doula services and to make those services available through network doulas. It also requires coverage for testosterone replacement therapy for menopausal women and otherwise preserves existing hormone replacement therapy coverage rules, while prohibiting certain discriminatory practices by insurers and providers related to that coverage. In addition, it bars health carriers from refusing to contract with a provider solely because the provider is a solo practitioner.
SB192 also adds a child welfare requirement for children in agency custody who have been diagnosed with a mental or behavioral health condition. Before such a child leaves custody, the agency must arrange an independent assessment by a qualified mental health professional, unless a later assessment has already determined the child no longer has the condition. The bill makes conforming changes to juvenile and family court provisions and nursing board rules to support that process.
A major policy component of the bill is its restriction on race-based health formulas and race-based care standards. The medical, nursing, and osteopathic licensing boards must adopt regulations listing any race-based formulas or standards that are authorized for use, but may not include any such practice if a scientifically validated race-neutral alternative is at least as effective. Health professionals may not use race-based formulas or standards that are not on the approved lists. The bill also directs the state’s medical schools and licensing boards to study disparities in health care access, treatment, and outcomes, including the historical and current use of race-based formulas and their effects.
The bill’s impact on state law is substantial because it amends multiple chapters of Nevada insurance and health law, creates new facility obligations, and authorizes enforcement through licensing actions and administrative penalties. The general sentiment reflected in the vote history suggests the bill was controversial but ultimately advanced with majority support in both chambers. The main points of contention appear to be the breadth of the mandates, especially the insurance coverage requirements, the race-based medicine restrictions, and the new obligations imposed on hospitals, insurers, and child welfare agencies. The bill also contains unfunded mandate language, indicating concern about implementation costs for state and local governments.
SB192 amends numerous provisions of Nevada law, including chapters governing hospitals and medical facilities, child welfare proceedings, nursing and physician licensing, and multiple categories of health insurance and managed care. It creates new duties for birthing facilities, expands mandated insurance benefits for doula services and hormone replacement therapy, restricts the use of race-based clinical formulas and standards, and requires independent mental health reassessments for certain children leaving child welfare custody. It also authorizes regulatory enforcement by the Insurance Commissioner and health licensing boards, including suspension or revocation authority in some cases, and includes effective dates that phase in most provisions on January 1, 2026.
The bill appears to have received mixed but ultimately favorable treatment. There is no committee transcript available, but the voting history shows it passed the Senate and Assembly with clear majorities, though not unanimously, indicating meaningful support alongside notable opposition. The overall sentiment suggests the bill was viewed by supporters as a broad patient- and consumer-protection measure, while opponents likely objected to its regulatory scope and mandated coverage requirements.
The most likely areas of contention are the insurance mandates, particularly the requirement that many plans cover doula services and testosterone replacement therapy for menopausal women, and the prohibition on insurers discouraging or limiting those benefits. Another major point of debate is the bill’s restrictions on race-based health formulas and race-based care standards, which could be seen by supporters as preventing discriminatory or outdated medical practices but by critics as potentially limiting clinical discretion or raising implementation questions. The child welfare assessment requirement and the birthing-room access provisions may also have raised operational and cost concerns for agencies and facilities, especially given the bill’s unfunded mandate designation.